Clinical trial

EMD 128130 for the Treatment of Parkinson's Disease

NCT00009048

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention EMD 128130 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention IV Levodopa Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

EMD 128130 for the Treatment of Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE2

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Interventions

EMD 128130DRUG

IV LevodopaDRUG

Sponsors & collaborators

National Institute of Neurological Disorders and Stroke (NINDS)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00009048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.